STOCK TITAN
  1. Home
  2. Sec-filings
  3. MSCLF
  4. [CERT] Satellos Bioscience Inc. Certification Filing

[CERT] Satellos Bioscience Inc. Certification Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
CERT
CERT - Satellos Bioscience Inc.

CERT Filing - Satellos Bioscience Inc.

This filing is available as a PDF document.

Filing Type: CERT

Company: Satellos Bioscience Inc. (MSCLF)

Acceptance Date: 2026-02-06T08:14:22.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Satellos Bioscience Inc

OTC:MSCLF

View MSCLF Stock Overview →

MSCLF Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

MSCLF Latest News

Feb 12, 2026
Satellos Announces First Participant Dosed in Phase 2 Pediatric Study of SAT-3247 for Duchenne Muscular Dystrophy
Feb 5, 2026
Satellos Announces Launch of Public Offering in Canada and the United States and Filing of Application to List on Nasdaq
Jan 29, 2026
Satellos Appoints Antoinette Paone as Chief Development Officer and Head of Regulatory Affairs
Jan 28, 2026
Satellos Announces Share Consolidation in Connection with Proposed Nasdaq Listing
Dec 9, 2025
Satellos Receives Clearance by U.S. FDA and Global Regulators to Initiate Pediatric Phase 2 Study of SAT-3247 for Duchenne Muscular Dystrophy

MSCLF Latest SEC Filings

Mar 27, 2026
[40-F] Satellos Bioscience Inc. Annual Report (Canadian Issuer)
Mar 27, 2026
[40-F] Satellos Bioscience Inc. Annual Report (Canadian Issuer)
Mar 27, 2026
[6-K] Satellos Bioscience Inc. Current Report (Foreign Issuer)
Mar 27, 2026
[6-K] Satellos Bioscience Inc. Current Report (Foreign Issuer)
Mar 10, 2026
[6-K] Satellos Bioscience Inc. Current Report (Foreign Issuer)

MSCLF Stock Data

187.67M
169.88M
Biotechnology
Healthcare
Link
Canada
Toronto